Empirical Finance, LLC Merck & Co., Inc. Transaction History

Empirical Finance, LLC

$1.62 Billion
Q1 2024

A detailed history of Empirical Finance, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Empirical Finance, LLC holds 91,929 shares of MRK stock, worth $11.6 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

91,929

Previous 88,274 4.14%

Holding current value

$11.6 Million

Previous $9.09 Million 33.49%

% of portfolio

0.75%

Previous 0.67%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$113.24 - $131.95 $413,892 - $482,277	3,655 Added 4.14%	91,929 $12.1 Million
Q3 2023 Nov 02, 2023	BUY	$102.95 - $114.33 $916,563 - $1.02 Million	8,903 Added 11.22%	88,274 $9.09 Million
Q2 2023 Jul 27, 2023	BUY	$108.61 - $118.38 $976,403 - $1.06 Million	8,990 Added 12.77%	79,371 $9.16 Million
Q1 2023 Apr 05, 2023	BUY	$102.94 - $114.86 $394,260 - $439,913	3,830 Added 5.75%	70,381 $7.49 Million
Q4 2022 Jan 24, 2023	BUY	$87.44 - $112.11 $439,998 - $564,137	5,032 Added 8.18%	66,551 $7.38 Million

Q3 2022 Nov 04, 2022	BUY	$84.53 - $94.96 $844,961 - $949,220	9,996 Added 19.4%	61,519 $5.3 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $229,347 - $259,976	2,747 Added 5.63%	51,523 $4.7 Million
Q1 2022 Apr 21, 2022	BUY	$73.51 - $82.4 $728,263 - $816,336	9,907 Added 25.49%	48,776 $4 Million
Q4 2021 Feb 04, 2022	BUY	$72.28 - $90.54 $494,901 - $619,927	6,847 Added 21.38%	38,869 $2.98 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $127,518 - $140,238	1,779 Added 5.88%	32,022 $2.41 Million
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $302,051 - $334,099	4,296 Added 16.56%	30,243 $2.35 Million
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $320,022 - $355,159	4,459 Added 20.75%	25,947 $2.12 Million
Q3 2020 Oct 28, 2020	BUY	$73.18 - $82.95 $1.11 Million - $1.26 Million	15,231 Added 243.42%	21,488 $1.78 Million
Q3 2020 Oct 26, 2020	SELL	$73.18 - $82.95 $796,783 - $903,159	-10,888 Reduced 63.51%	6,257 $527,000
Q2 2020 Jul 20, 2020	BUY	$70.42 - $80.13 $348,508 - $396,563	4,949 Added 40.58%	17,145 $1.33 Million
Q2 2020 Jul 20, 2020	SELL	$70.42 - $80.13 $186,260 - $211,943	-2,645 Reduced 17.82%	12,196 $1.33 Million
Q1 2020 Apr 16, 2020	BUY	$63.36 - $87.82 $320,284 - $443,930	5,055 Added 51.66%	14,841 $1.14 Million
Q4 2019 Jan 27, 2020	BUY	$77.58 - $87.54 $273,779 - $308,928	3,529 Added 56.4%	9,786 $890,000
Q3 2019 Oct 30, 2019	BUY	$76.08 - $82.93 $8,520 - $9,288	112 Added 1.82%	6,257 $527,000
Q2 2019 Jul 09, 2019	SELL	$69.84 - $81.59 $8,660 - $10,117	-124 Reduced 1.98%	6,145 $515,000
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $99,290 - $113,246	1,427 Added 29.47%	6,269 $521,000
Q4 2018 Jan 22, 2019	SELL	$65.24 - $75.71 $30,597 - $35,507	-469 Reduced 8.83%	4,842 $370,000
Q3 2018 Oct 18, 2018	BUY	$57.69 - $67.84 $33,921 - $39,889	588 Added 12.45%	5,311 $377,000
Q2 2018 Jul 09, 2018	SELL	$50.83 - $59.72 $78,583 - $92,327	-1,546 Reduced 24.66%	4,723 $287,000
Q1 2018 May 10, 2019	BUY	$50.96 - $59.23 $319,468 - $371,312	6,269 New	6,269 $521,000

Others Institutions Holding MRK

# of Institutions

3,770

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Account

Empirical Finance, LLC Merck & Co., Inc. Transaction History